Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy
Background:
Dilated cardiomyopathy is associated with increased risk of major cardiovascular events. Late gadolinium enhancement (LGE) cardiac magnetic resonance imaging is a unique tissue-based marker that, in single-center studies, suggests strong prognostic value. We retrospectively studied associations between LGE presence and adverse cardiovascular events in patients with dilated cardiomyopathy in a multicenter setting as part of an emerging global consortium (MINICOR [Multi-Modal International Cardiovascular Outcomes Registry]).
Methods:
Consecutive patients with dilated cardiomyopathy referred for cardiac magnetic resonance (2000–2017) at 12 institutions in 4 countries were studied. Using multivariable Cox proportional hazard and semiparametric Fine and Gray models, we evaluated the association between LGE and the composite primary end point of all-cause mortality, heart transplantation, or left ventricular assist device implant and a secondary arrhythmic end point of sudden cardiac death or appropriate implantable cardioverter-defibrillator shock.
Results:
We studied 1672 patients, mean age 56±14 years (29% female), left ventricular ejection fraction 33±11%, and 25% having New York Heart Association class III to IV; 650 patients (39%) had LGE. During 2.3 years (interquartile range, 1.0–4.3) follow-up, 160 patients experienced the primary end point, and 88 experienced the arrhythmic end point. In multivariable analyses, LGE was associated with 1.5-fold (hazard ratio, 1.45 [95% CI, 1.03–2.04]) risk of the primary end point and 1.8-fold (hazard ratio, 1.82 [95% CI, 1.20–3.06]) risk of the arrhythmic end point. Primary end point risk was increased in patients with multiple LGE patterns, although arrhythmic risk was higher among patients receiving primary prevention implantable cardioverter-defibrillator and widening QRS.
Conclusions:
In this large multinational study of patients with dilated cardiomyopathy, the presence of LGE showed strong prognostic value for identification of high-risk patients. Randomized controlled trials evaluating LGE-based care management strategies are warranted.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Journal of Cardiovascular Magnetic Resonance
5 publications, 5.38%
|
|
|
Journal of Clinical Medicine
4 publications, 4.3%
|
|
|
Scientific Reports
3 publications, 3.23%
|
|
|
Frontiers in Cardiovascular Medicine
3 publications, 3.23%
|
|
|
Journal of Magnetic Resonance Imaging
3 publications, 3.23%
|
|
|
Heart Failure Clinics
3 publications, 3.23%
|
|
|
European Journal of Heart Failure
2 publications, 2.15%
|
|
|
Circulation
2 publications, 2.15%
|
|
|
Korean Journal of Radiology
2 publications, 2.15%
|
|
|
Biomedicines
2 publications, 2.15%
|
|
|
Journal of Interventional Cardiac Electrophysiology
2 publications, 2.15%
|
|
|
JACC: Cardiovascular Imaging
2 publications, 2.15%
|
|
|
European Heart Journal, Supplement
2 publications, 2.15%
|
|
|
Heart
2 publications, 2.15%
|
|
|
American Journal of Cardiology
2 publications, 2.15%
|
|
|
European Heart Journal
2 publications, 2.15%
|
|
|
Journal of Cardiovascular Development and Disease
2 publications, 2.15%
|
|
|
Journal of the American College of Cardiology
2 publications, 2.15%
|
|
|
Echocardiography
2 publications, 2.15%
|
|
|
European Radiology
2 publications, 2.15%
|
|
|
Reviews in Cardiovascular Medicine
2 publications, 2.15%
|
|
|
International Journal of Arrhythmia
1 publication, 1.08%
|
|
|
Circulation: Cardiovascular Imaging
1 publication, 1.08%
|
|
|
Diagnostics
1 publication, 1.08%
|
|
|
Journal of Medical Case Reports
1 publication, 1.08%
|
|
|
Cardiovascular Pathology
1 publication, 1.08%
|
|
|
REC: CardioClinics
1 publication, 1.08%
|
|
|
Journal of Cardiac Failure
1 publication, 1.08%
|
|
|
Heart Rhythm O2
1 publication, 1.08%
|
|
|
1
2
3
4
5
|
Publishers
|
5
10
15
20
25
30
|
|
|
Elsevier
27 publications, 29.03%
|
|
|
Springer Nature
13 publications, 13.98%
|
|
|
MDPI
12 publications, 12.9%
|
|
|
Wiley
9 publications, 9.68%
|
|
|
Oxford University Press
7 publications, 7.53%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 publications, 3.23%
|
|
|
Frontiers Media S.A.
3 publications, 3.23%
|
|
|
AME Publishing Company
3 publications, 3.23%
|
|
|
BMJ
2 publications, 2.15%
|
|
|
IMR Press
2 publications, 2.15%
|
|
|
The Korean Society of Radiology
1 publication, 1.08%
|
|
|
Georg Thieme Verlag KG
1 publication, 1.08%
|
|
|
Silicea - Poligraf, LLC
1 publication, 1.08%
|
|
|
Edizioni Minerva Medica
1 publication, 1.08%
|
|
|
Baishideng Publishing Group
1 publication, 1.08%
|
|
|
XMLink
1 publication, 1.08%
|
|
|
Radiological Society of North America (RSNA)
1 publication, 1.08%
|
|
|
American Roentgen Ray Society
1 publication, 1.08%
|
|
|
American Medical Association (AMA)
1 publication, 1.08%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 1.08%
|
|
|
The Scientific and Practical Society of Emergency Medicine Physicians
1 publication, 1.08%
|
|
|
5
10
15
20
25
30
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.